Percivia, a joint venture between a large pharmaceutical manufacturer and a biopharmaceutical, is the developer of the PER.C6 technology. The new company held a unique place in the market: its technology was far more effective than any others, but competing technology was more widely accepted. Eye Integrated developed a name, an eye-catching corporate identity, and a branding strategy that helped increase both industry awareness of PER.C6 and licenses.